Alan D. Sobel - Feb 14, 2022 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
Director
Signature
/s/ Kathleen P. Bloch attorney-in-fact for Alan D. Sobel
Stock symbol
CTSO
Transactions as of
Feb 14, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 03:31 PM
Next filing
May 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTSO Common Stock Gift $0 +2K $0.00 2K Feb 14, 2022 Bernard Sobel Revocable Trust F1
holding CTSO Common Stock 69.3K Feb 14, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in the Bernard Sobel Revocable Trust (the "Trust'"). On February 14, 2022, the reporting person became a trustee of the Trust. The reporting person is also a named beneficiary of the Trust. Accordingly, the reporting person may be deemed the beneficial owner of the shares held in the Trust.
F2 Includes the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015.